Prehospital Evaluation and Economic Analysis of Different Coronary Syndrome Treatment Strategies - PREDICT
PREDICT
The Impact of Prehospital 12 Lead ECG With Advanced Emergency Department Notification on Time to In-hospital Reperfusion Strategy in Patients With Acute ST Segment Elevation Myocardial Infarction - A Prospective Study
1 other identifier
observational
446
1 country
5
Brief Summary
Despite remarkable gains in treatment over the last decade short-term mortality for those who survive to hospital with AT-elevation acute myocardial infarction (STEMI) remains high (5%-10%). Different studies have pointed out that reperfusion (intravenous fibrinolysis or percutaneous coronary interventions (PCI) and its timing are critical in decreasing STEMI patients' mortality. Studies of prehospital 12 lead electrocardiograms (12 lead PHECG) with advance emergency department (ED) notification suggest that there is a time to treatment advantage with this intervention. The use of 12 lead PHECG is not currently universal and part of standard treatment throughout the province. The purpose of the study is to follow STEMI study subjects during standard treatments and to compare the outcomes of subjects that received 12 lead PHECG with advanced ED notification in mixed rural/urban areas with outcomes of subjects treated in areas with only 3 lead PHECG monitoring and indirect ED notification. The investigators hypothesize that there will be a survival benefit for study subjects with 12 lead PHECG and advance ED notification in rural and urban environments through a reduction in door-to-reperfusion time and that 12 lead PHECG will be a cost-saving technology for the province of Ontario.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2009
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 4, 2008
CompletedFirst Posted
Study publicly available on registry
September 5, 2008
CompletedStudy Start
First participant enrolled
February 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFebruary 12, 2018
February 1, 2018
4.1 years
September 4, 2008
February 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of the time from arrival to the ED to initiation of the reperfusion therapy between those receiving 12 lead PHECG and those receiving 3 lead PHECG monitoring prior to hospital arrival.
24 hours
Secondary Outcomes (2)
Survival at 30 days
30 days
Cost-effectiveness
1 year
Study Arms (4)
1
3 lead ECG subjects with chest pain and suspected ischemia transported to the nearest receiving ED and not eligible for bypass based on transport time
2
3 lead ECG subjects with chest pain and suspected ischemia transported to the nearest receiving ED and eligible for bypass based on transport time, if 12 lead PHECG was possible
3
12 lead ECG subjects with prehospital notification transported to nearest receiving ED adn not eligible for bypass to PCI center based on transport time
4
12 lead PHECG subjects with prehospital notification bypassed past the nearest receiving ED to the PCI center.
Eligibility Criteria
This study will be conducted across Ontario. Selected regions representing approximately 17% of the population of Ontario and 6.4% of the popluation of Canada. Covering an area of 181426 per square kilometers with variable population densities from 2.5 to 234 person per square kilometers and representing rural, suburban, urban, and metropolis areas will be the catchment area for the study. A variety of EMS operators under the control of EMS Base Hospital programs will be involved in the data collection for this study. Patients presenting with suspected ischemic chest pain will be tracked as a part of the trial.
You may qualify if:
- Call 911 for assistance
- Are suspected by the paramedics of having ischemic chest pain for greater than 30 minutes but less than 6 hours
- Be greater than or equal to 18 years of age
- Experience chest pain that fails to completely respond to nitrates as per standard provincial chest pain protocol.
You may not qualify if:
- Subjects less than 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Stevenson Memorial Hospital
Alliston, Ontario, L9R 1W7, Canada
Sudbury Regional Hospital
Greater Sudbury, Ontario, M4N 3M5, Canada
Southlake Regional Health Centre
Newmarket, Ontario, L3Y 2P9, Canada
Rouge Valley
Toronto, Ontario, Canada
Sunnybrook Health Scineces Centre
Toronto, Ontario, Canada
Related Publications (1)
Morrison LJ, Rac VE, Bowen JM, Schwartz B, Perreira T, Ryan W, Zahn C, Chadha R, Craig A, O'Reilly D, Goeree R. Prehospital evaluation and economic analysis of different coronary syndrome treatment strategies--PREDICT--rationale, development and implementation. BMC Emerg Med. 2011 Mar 29;11:4. doi: 10.1186/1471-227X-11-4.
PMID: 21447161BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurie Morrison, MD, MSc
Prehospital & Transport Medicine Research, Sunnybrook Health Sciences Centre
- PRINCIPAL INVESTIGATOR
Ron Goeree, MA
Programs for Assessments of Technology in Health Reasearch Institute, St. Joseph's Healthcare Hamilton
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 4, 2008
First Posted
September 5, 2008
Study Start
February 1, 2009
Primary Completion
March 1, 2013
Study Completion
May 1, 2013
Last Updated
February 12, 2018
Record last verified: 2018-02